Navigation Links
First Warning Systems Receives Investment by Members of the Reno Angels and Local Investors
Date:8/6/2012

RENO, Nev., Aug. 6, 2012 /PRNewswire/ -- First Warning Systems, Inc. announces members of the Reno Angels have joined together with local investors to invest in the First Warning Systems $1,000,000 Series A funding round. 

Jim Holmes, First Warning's CEO states, "We are approaching fifty percent completion of this Series A round of financing.  We appreciate members of the Reno Angels and local investors' support of the First Warning System." 

For particulars concerning the Series A round, please check First Warning's website: www.firstwarningsystems.com/series-a-funding.html.

The First Warning patented technology uses predictive analytics software to penetrate imaging technology barriers that are limited to viewing a tumor that, on average, has been growing for 11 years.  Deep tissue temperature analysis from 12 hours of dynamic data collection is modeled using predictive analytics software to compare circadian body rhythms that can identify abnormalities up to 6 years prior to imaging technologies. The First Warning product vision video can be seen at www.firstwarningsystems.com

Holmes adds, "We are planning the establishment of a production facility for our products, determining employee requirements to support worldwide marketing and sales.  We are investigating and hopeful of being able to establish these operations in the Truckee Meadows area."        

About First Warning Systems

First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS' principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO). FWS holds the exclusive worldwide license from Lifeline Biotechnologies for development, manufacturing and marketing of the software-based technologies. The FWS product line is a patented device and process that detects breast tissue abnormalities for health risk assessment and management earlier than any other known modalities.  These tissue abnormalities can lead to breast cancers. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes with industry leading 90% accuracy.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS predictive analytics product.  FWS is preparing for Euro CE Mark and marketing in the UK, EU and Russian markets.  For more information check www.firstwarningsystems.com

For more information, contact: Jim Holmes, CEO 775-324-3822 or 775-852-3222, jholmes@firstwarningsystems.com 


'/>"/>
SOURCE First Warning Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
2. Midwest Health Care Startups Raise $511 Million in First Half of 2012
3. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
4. Target for potent first-strike influenza drugs identified
5. Genelex Receives First Patent on Business Methods for Pharmacogenetics
6. TI introduces the industrys first weigh scale and body composition analog front end
7. Midwest Health Care Startups Raise $491 Million in First Half of 2012
8. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
9. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
10. AHIMA Launches First HIM Career Map
11. MIOT Hospital Delivers First TrueBeam STx Radiotherapy Treatment in Chennai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):